Macquarie Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,678
| Closed | -$1.89M | – | 1948 |
|
|
2024
Q1 | $1.89M | Buy |
+27,678
| New | +$1.89M | ﹤0.01% | 1238 |
|
|
2023
Q2 | – | Sell |
-623
| Closed | -$28K | – | 1663 |
|
|
2023
Q1 | $28K | Sell |
623
-39,318
| -98% | -$1.77M | ﹤0.01% | 1650 |
|
|
2022
Q4 | $1.62M | Sell |
39,941
-797,494
| -95% | -$32.4M | ﹤0.01% | 1265 |
|
|
2022
Q3 | $54.8M | Buy |
837,435
+747,413
| +830% | +$48.9M | 0.07% | 395 |
|
|
2022
Q2 | $5.47M | Buy |
90,022
+88,055
| +4,477% | +$5.35M | 0.01% | 1013 |
|
|
2022
Q1 | $123 | Hold |
1,967
| – | – | ﹤0.01% | 1894 |
|
|
2021
Q4 | $149K | Sell |
1,967
-982,923
| -100% | -$74.5M | ﹤0.01% | 1829 |
|
|
2021
Q3 | $110M | Sell |
984,890
-174,877
| -15% | -$19.6M | 0.09% | 274 |
|
|
2021
Q2 | $188M | Buy |
1,159,767
+1,155,532
| +27,285% | +$187M | 0.15% | 153 |
|
|
2021
Q1 | $516K | Sell |
4,235
-156,100
| -97% | -$19M | ﹤0.01% | 1528 |
|
|
2020
Q4 | $24.5M | Buy |
160,335
+93,291
| +139% | +$14.3M | 0.04% | 466 |
|
|
2020
Q3 | $5.61M | Sell |
67,044
-28,296
| -30% | -$2.37M | 0.01% | 799 |
|
|
2020
Q2 | $7.01M | Buy |
+95,340
| New | +$7.01M | 0.01% | 712 |
|
|
2018
Q1 | – | Sell |
-600
| Closed | -$14K | – | 2207 |
|
|
2017
Q4 | $14K | Buy |
+600
| New | +$14K | ﹤0.01% | 2229 |
|